Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 Treatment
Description
We developed a computational framework that integrates Genome-Wide Association Studies (GWAS) and post-GWAS analyses, designed to facilitate drug repurposing for COVID-19 treatment. The comprehensive approach combines transcriptomic-wide associations
